文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

医疗性心脏骤停自主循环恢复后院前急诊麻醉的心血管并发症:基于氯胺酮与基于咪达唑仑诱导方案的回顾性比较

Cardiovascular complications of prehospital emergency anaesthesia in patients with return of spontaneous circulation following medical cardiac arrest: a retrospective comparison of ketamine-based and midazolam-based induction protocols.
PubMed 文献 · Emerg Med J · 2021-09-29
一句话结论心脏骤停ROSC后行院前急诊麻醉,氯胺酮与咪达唑仑诱导后低血压发生率无差异,选药本身不足以避免血流动力学紊乱。

主要终点为PHEA后30分钟内临床显著低血压,两组发生率分别为54.2%与50.7%(p=0.673),无显著差异;30分钟内平均最大心率分别为119次/分与122次/分(p=0.523)。结论认为仅选择诱导药物不足以减轻血流动力学紊乱,需采用其他策略。

要点

  • 医疗性心脏骤停ROSC后行PHEA,30分钟内临床显著低血压总体发生率高:氯胺酮组54.2%、咪达唑仑组50.7%(p=0.673)。
  • 氯胺酮基于中位剂量1.00 mg/kg与咪达唑仑基于中位剂量0.03 mg/kg诱导后低血压无显著差异,不良事件率亦无显著差异。
  • 仅选择诱导药物不足以减轻ROSC后PHEA的血流动力学紊乱,应考虑其他策略。

适用人群与场景

  • 医疗性心脏骤停后自主循环恢复(ROSC)且需院前急诊麻醉(PHEA)的患者,由直升机紧急医疗服务(HEMS)实施。

诊断标准与关键阈值

  • 主要终点为PHEA后30分钟内临床显著低血压,定义为新发收缩压<90 mmHg,或若诱导前收缩压已<90 mmHg则下降10%。

处置流程与药物剂量

  • 咪达唑仑基于诱导:150例,中位剂量(IQR)0.03(0.02-0.04)mg/kg,给药途径原文未提及。
  • 原文未提及具体给药频次、疗程或目标值。

红旗征与不能漏的情况

  • PHEA后30分钟内临床显著低血压(新发收缩压<90 mmHg或诱导前<90 mmHg者下降10%)发生率高,需警惕。
  • 休克指数>1.0次/min/mmHg与年龄>70岁提示PHEA后低血压风险增高。
  • 原文未提及具体需要立刻处理或不能漏诊的情况及对应处理。

研究设计与关键结果

  • 研究类型:回顾性数据库 review,单中心(Essex & Herts Air Ambulance Trust),5年期间(2014年12月至2019年12月)。
  • 人群:医疗性心脏骤停ROSC后需PHEA的患者。
  • 干预与对照:基于氯胺酮的诱导方案 vs 基于咪达唑仑的诱导方案。
  • 主要终点:PHEA后30分钟内临床显著低血压发生率,氯胺酮组54.2% vs 咪达唑仑组50.7%(p=0.673),无显著差异。
  • 关键次要终点:30分钟内平均最大心率氯胺酮组119次/分 vs 咪达唑仑组122次/分(p=0.523);不良事件率两组无显著差异。

证据类型、等级与局限

  • 证据类型:回顾性数据库 review(观察性研究)。

对床旁实践的改变

  • 对于医疗性心脏骤停ROSC后需PHEA的患者,选择氯胺酮或咪达唑仑诱导在低血压发生上无显著差异,不能仅靠选药来避免血流动力学紊乱。
  • 应关注休克指数>1.0次/min/mmHg和年龄>70岁的患者,其PHEA后低血压风险更高。
  • 需采用其他策略(原文未具体说明)来应对PHEA后的血流动力学紊乱。
  • 适用人群:医疗性心脏骤停ROSC后需PHEA的患者;不适用人群:原文未提及。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Hypotension following intubation and return of spontaneous circulation (ROSC) after cardiac arrest is associated with poorer patient outcomes. In patients with a sustained ROSC requiring emergency anaesthesia, there is limited evidence to guide anaesthetic practice. At the Essex & Herts Air Ambulance Trust, a UK-based helicopter emergency medical service, we assessed the relative haemodynamic stability of two different induction agents for post-cardiac arrest medical patients requiring prehospital emergency anaesthesia (PHEA).

METHODS: We performed a retrospective database review over a 5-year period between December 2014 and December 2019 comparing ketamine-based and midazolam-based anaesthesia in this patient cohort. Our primary outcome was clinically significant hypotension within 30 min of PHEA, defined as a new systolic BP less than 90 mm Hg, or a 10% drop if less than 90 mm Hg before induction.

RESULTS: One hundred ninety-eight patients met inclusion criteria. Forty-eight patients received a ketamine-based induction, median dose (IQR) 1.00 (1.00-1.55) mg/kg, and a 150 midazolam-based regime, median dose 0.03 (0.02-0.04) mg/kg. Hypotension occurred in 54.2% of the ketamine group and 50.7% of the midazolam group (p=0.673). Mean maximal HRs within 30 min of PHEA were 119 beats/min and 122 beats/min, respectively (p=0.523). A shock index greater than 1.0 beats/min/mm Hg and age greater than 70 years were both associated with post-PHEA hypotension with ORs 1.96 (CI 1.02 to 3.71) and 1.99 (CI 1.01 to 3.90), respectively. Adverse event rates did not significantly differ between groups.

CONCLUSION: PHEA following a medical cardiac arrest is associated with potentially significant cardiovascular derangements when measured up to 30 min after induction of anaesthesia. There was no demonstrable difference in post-induction hypotension between ketamine-based and midazolam-based PHEA. Choice of induction agent alone is insufficient to mitigate haemodynamic disturbance, and alternative strategies should be used to address this.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. King C, Lewinsohn A, Keeliher C, et al. Cardiovascular complications of prehospital emergency anaesthesia in patients with return of spontaneous circulation following medical cardiac arrest: a retrospective comparison of ketamine-based and midazolam-based induction protocols. Emerg Med J. 2021. PMID: 34588175. doi:10.1136/emermed-2020-210531

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。